By Professor Miles Davenport

Preprints

Selva KJ; Davis SK; Haycroft ER; Lee WS; Lopez E; Reynaldi A; Davenport MP; Kent HE; Juno JA; Chung AW; Kent SJ, Tear antibodies to SARS-CoV-2: implications for transmission, http://dx.doi.org/10.1101/2021.08.02.21261479

Pampena MB; Samer S; Viox EG; Nguyen K; Deleage C; Kuri-Cervantes L; Regan J; Wu VH; Docken S; Safrit JT; Bar KJ; Keele BF; Davenport MP; Paiardini M; Betts MR, Therapeutic CD8+T cell tissue retention and immunomodulation during ART interruption fails to prevent SIV rebound, http://dx.doi.org/10.1101/2025.03.17.643755

Moriarty RV; Fesser N; Sutton MS; Venturi V; Davenport MP; Schlub T; O'Connor SL, Validation of multiplex PCR sequencing assay of SIV, http://dx.doi.org/10.21203/rs.3.rs-35062/v2

Moriarty RV; Fesser N; Sutton MS; Venturi V; Davenport MP; Schlub T; O'Connor SL, Validation of multiplex PCR sequencing assay of SIV, http://dx.doi.org/10.21203/rs.3.rs-35062/v1

Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.06.18.23291566

Back to profile page